Overweight (BMI > 25): Clinical Trials

27 trials for Overweight (BMI > 25), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 8 recruiting, 4 not yet recruiting, 3 enrolling by invitation. 22 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable22Completed 7, Recruiting 6, Not yet recruiting 4, Active not recruiting 2, Enrolling by invitation 2, Unknown 1
Phase 21Recruiting 1

Follow Overweight (BMI > 25): new trials by email Literature Review of Overweight (BMI > 25) trials Research Report on Overweight (BMI > 25)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fasting, Exercise, and Diet to Activate Autophagy in Depression
Performance test - Depression - Major Depressive Disorder, Overweight (BMI > 25)
Not applicableNot yet recruitingUniversity of Zurich1202026-09-112026-06-24
SSRD and Overweight
Dietary intervention with SSRD in combination with feedback information about the metabolic profile, Dietary intervention with SSRD without any feedback on metabolic profile - Overweight (BMI > 25)
Not applicableNot yet recruitingRegion Skane3002026-09-012026-04-29
Assessment of Metabolic Changes in Response to Glcuose Intake in Women With Polyendocrine Metabolic Ovarian Syndrome (PMOS)
Oral Clucose Tolerance Test (oGTT) - PCOS (Polycystic Ovary Syndrome), Insulinemic Response
Not applicableNot yet recruitingUniversity of Zurich402026-08-012026-07-07
Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.
Avocado, Control - Overweight (BMI > 25), Obesity (BMI>30)
Not applicableRecruitingMidwest Center for Metabolic and Cardiovascular Research382026-07-022026-08-27
AIM-WEIGHT: AI-Guided Microbiome-Targeted Nutritional Intervention for Weight Loss
AI-Guided Microbiome-Targeted Nutritional Supplement, Matching Placebo (B), Lifestyle counselling - Overweight (Without Type 2 Diabetes) With Weight-related Comorbidities, Overweight (BMI > 25)
Not applicableEnrolling by invitationVarol TUNALI802026-07-012026-09-29
IMPACT: Immune and Musculoskeletal Physiological Adaptations to Combined Exercise Training & Nutrition
Milk, Greek Yogurt, Exercise training - Overweight (BMI > 25), Males and Females
Not applicableNot yet recruitingYork University602026-05-012026-04-07
To Test the Effectiveness and Implementation Approach of a 3-month PILI Pasifika Program Lifestyle Program With Components of Social Determinants of Health Activities in Real-world Settings (Clinical and Non-clinical Settings) Across 3 Years
PILI (Partnership for Improving Lifestyle Intervention) Pasifika Program - Cardiometabolic Conditions, Hypertension (HTN)
Not applicableEnrolling by invitationUniversity of Hawaii4002026-05-012026-06-09
Effect of Probiotics on Appetite Regulation in Adults With Overweight/Obesity
Probiotic supplementation, Placebo - Healthy, Overweight (BMI > 25)
Not applicableRecruitingMaastricht University Medical Center982026-03-182026-08-12
Sustainable and Inclusive Use of Alternative Proteins in Mediterranean Supply Chains (CIPROMED)
Mediterranean Diet with Control Products (chronic phase), Mediterranean Diet with Insect Protein Bread (chronic phase), Mediterranean Diet with Seaweed-Based Burger (chronic phase) - Food Preferences, Satiety and Food Intake
Not applicableRecruitingUniversity of Bologna402026-03-182026-05-04
Limosilactobacillus Fermentum CRL 1446 - CONICET CASASCO
Limosilactobacillus fermentum 1446 CRL CONICET 2.20E+9 CFU, Placebo (inert excipient) - Disbiosis, Obesity
Not applicableActive not recruitingPINER Pastor Manfredi Winery802026-02-022026-05-14
Time Restricted-EAting for Type 2 Diabetes and MEtabolic Health: the TEA TIME Trial
Time-restricted eating, Standard lifestyle - Type 2 Diabetes, Overweight (BMI > 25)
Not applicableRecruitingMount Sinai Hospital, Canada1122026-02-012026-02-11
Gummy Candies With Maqui Berry
GM, Control, GMM - Overweight (BMI > 25), Obesity & Overweight
Not applicableCompletedGonzalo Jorquera, PhD102025-12-022026-01-28
Effects of Yerba Mate Supplementation on Metabolic Health, Physical Function, and Cognition in Older Adults With Excess Adiposity
Yerba Mate, Placebo - Overweight (BMI > 25), Obesity & Overweight
Not applicableCompletedUniversity of North Alabama252025-11-152026-10-20
Effect of Low Volume Sprint Interval Training on Cardiorespiratory Fitness
High intensity interval training - Inactivity, Physical, Overweight (BMI > 25)
Not applicableRecruitingCalifornia State University, San Marcos602025-11-052026-08-24
Global Overweight and oBesE (GLOBE) Patient Registry, Development and Implementation of Disease-specific: Severity, Quality of Life and Cost Instruments.
Overweight (BMI > 25), Obesity & Overweight
RecruitingMedialis Ltd.5002025-11-012025-11-14
Anti-Inflammatory Effects of Pecan Nut Oil Supplementation in Adults With Overweight: A Randomized Controlled Parallel-Group Clinical Trial
Pecan nut oil supplementation - Overweight (BMI > 25)
Not applicableRecruitingUniversidad Autonoma de Nuevo Leon502025-10-152026-03-27
Effect of Ketone Esters on Liver Fat Content and Metabolic Function
bis-octanoyl (R)-1,3-butanediol (C8 ketone di-ester), Placebo - MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, Obesity
Phase 2RecruitingWashington University School of Medicine402025-09-262026-07-15
Intervention Based on the Dietary Guidelines for the Brazilian Population for the Treatment of Overweight and Obesity
Collective Intervention Based on the Dietary Guidelines for the Brazilian Population, Control Group: Individualized Care - Obesity & Overweight, Overweight (BMI > 25)
Not applicableActive not recruitingFederal University of Health Science of Porto Alegre602025-05-012026-04-20
Combined Training (Strength and Endurance) and the Serum Levels of Myostatin and Hormone-sensitive Lipase in Overweight and Obese Men
Upper Body Combined Training, Lower Body Combined Training - Overweight (BMI > 25), Obesity (BMI>30)
Not applicableCompletedArya Habibi362024-05-012026-06-23
CHANGES IN SLEEP QUALITY AND BODY COMPOSITION FOLLOWING A MULTIMODAL LIFESTYLE INTERVENTION IN OLDER WOMEN
Multimodal Lifestyle Intervention - Obesity, Overweight (BMI > 25)
Not applicableCompletedSaglik Bilimleri Universitesi362024-01-152026-08-03

Showing 20 of 27. Sign in to see all of them.

Narrower conditions

Overweight (27)  ·  Obesity (12)  ·  Diabetes Mellitus, Type 2 (5)  ·  Hypertension (3)  ·  Weight Loss (3)  ·  Inflammation (2)  ·  Sleep Initiation and Maintenance Disorders (2)  ·  Depression (1)  ·  Diabetes Mellitus (1)  ·  Diabetes, Gestational (1)  ·  Dysbiosis (1)  ·  Dyslipidemias (1)  ·  Food Preferences (1)  ·  Glucose Intolerance (1)  ·  Hypercholesterolemia (1)

Broader conditions

Body Weight (27)  ·  Nutrition Disorders (27)  ·  Nutritional and Metabolic Diseases (27)  ·  Overnutrition (27)  ·  Pathological Conditions, Signs and Symptoms (27)  ·  Signs and Symptoms (27)  ·  Endocrine System Diseases (8)  ·  Glucose Metabolism Disorders (7)  ·  Metabolic Diseases (7)  ·  Diabetes Mellitus (6)  ·  Behavior (5)  ·  Pathologic Processes (4)  ·  Body Weight Changes (3)  ·  Cardiovascular Diseases (3)  ·  Lipid Metabolism Disorders (3)

Interventions

Diet Therapy (1)  ·  Diet, Mediterranean (1)  ·  Dietary Supplements (1)  ·  Exercise (1)  ·  Glucose Tolerance Test (1)  ·  High-Intensity Interval Training (1)  ·  Milk (1)

Sponsors

Maastricht University Medical Center (2)  ·  University of Zurich (2)  ·  Arya Habibi (1)  ·  Bioagile Therapeutics Pvt. Ltd. (1)  ·  California State University, San Marcos (1)  ·  Chang Gung Memorial Hospital (1)  ·  Federal University of Health Science of Porto Alegre (1)  ·  Gonzalo Jorquera, PhD (1)  ·  Hofseth Biocare ASA (1)  ·  Medialis Ltd. (1)  ·  Midwest Center for Metabolic and Cardiovascular Research (1)  ·  Mount Sinai Hospital, Canada (1)  ·  PINER Pastor Manfredi Winery (1)  ·  Region Skane (1)  ·  Saglik Bilimleri Universitesi (1)

Countries

United States (6)  ·  Canada (3)  ·  India (3)  ·  Switzerland (2)  ·  Turkey (Türkiye) (2)  ·  Argentina (1)  ·  Brazil (1)  ·  Chile (1)  ·  France (1)  ·  Iran (1)  ·  Italy (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Taiwan (1)  ·  United Kingdom (1)

Top investigators

Ali Abdul-Sater, PhD (1)  ·  Andrea Josse, PhD (1)  ·  Divya Divya (1)  ·  Freddy Halvadar, PhD (1)  ·  Jonathan Little (1)  ·  Joseph K Kaholokula, PhD (1)  ·  Maria Letizia Petroni, Professor (1)  ·  Nia Aitaoto, PhD (1)  ·  Nicholas Cheng, MSc (1)  ·  Poulami Dasgupta (1)  ·  Raul Francisco Pastor, MD (1)  ·  Samuel Klein, MD (1)  ·  Sheri-Ann Daniels, EdD (1)

Results publications

PMID 41818195, PMID 41872855

NIH funding

2025 (1), OT2HL158287 (1)